ATE547004T1 - Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen - Google Patents

Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen

Info

Publication number
ATE547004T1
ATE547004T1 AT06803714T AT06803714T ATE547004T1 AT E547004 T1 ATE547004 T1 AT E547004T1 AT 06803714 T AT06803714 T AT 06803714T AT 06803714 T AT06803714 T AT 06803714T AT E547004 T1 ATE547004 T1 AT E547004T1
Authority
AT
Austria
Prior art keywords
agarose
less
macrobeads
content
concentration
Prior art date
Application number
AT06803714T
Other languages
English (en)
Inventor
Lawrence Gazda
Barry Smith
Original Assignee
Rogosin Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst Inc filed Critical Rogosin Inst Inc
Application granted granted Critical
Publication of ATE547004T1 publication Critical patent/ATE547004T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • C12N5/0677Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/76Agarose, agar-agar
AT06803714T 2005-09-26 2006-09-14 Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen ATE547004T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72091705P 2005-09-26 2005-09-26
PCT/US2006/036125 WO2007038029A2 (en) 2005-09-26 2006-09-14 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof

Publications (1)

Publication Number Publication Date
ATE547004T1 true ATE547004T1 (de) 2012-03-15

Family

ID=37900243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06803714T ATE547004T1 (de) 2005-09-26 2006-09-14 Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen

Country Status (18)

Country Link
US (1) US8518394B2 (de)
EP (1) EP1928249B1 (de)
JP (1) JP4937265B2 (de)
KR (1) KR101110386B1 (de)
CN (1) CN101272690B (de)
AT (1) ATE547004T1 (de)
AU (1) AU2006295114B2 (de)
CA (1) CA2622529C (de)
DK (1) DK1928249T3 (de)
ES (1) ES2379008T3 (de)
HK (1) HK1116995A1 (de)
IL (1) IL190028A (de)
NO (1) NO341154B1 (de)
NZ (1) NZ566621A (de)
PL (1) PL1928249T3 (de)
PT (1) PT1928249E (de)
RU (1) RU2417090C2 (de)
WO (1) WO2007038029A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2777398T3 (pl) 2010-11-23 2017-09-29 The Rogosin Institute, Inc. Sposób izolowania opornych na środek chemioterapeutyczny komórek rakowych o właściwościach komórek macierzystych
HUE034618T2 (en) 2012-01-31 2018-02-28 The Rogosin Inst Inc An improved process for producing macros
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441878A (en) * 1987-12-08 1995-08-15 Thies Technology, Inc. Preparation of uniform droplets by using gas pressure to force liquid from a syringe and flowing gas to detach droplets
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose
JPH07505922A (ja) * 1992-07-23 1995-06-29 エフ エム シー コーポレーション グルコマンナンスポンジ状マトリックス
PT1418228E (pt) 1994-01-13 2006-09-29 Rogosin Inst Processo de preparacao de uma biblioteca multicombinatoria de vectores de expressao de genes de anticorpos.
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
US5888497A (en) 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6303151B1 (en) 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
CA2445363C (en) * 2003-10-17 2012-05-22 Francois Leblond Semi-permeable microcapsule with covalently linked layers and method for producing same
US6997864B2 (en) 2003-11-03 2006-02-14 Otologics, Llc Method for obtaining diagnostic information relating to a patient having an implanted transducer
WO2006055501A2 (en) * 2004-11-17 2006-05-26 The Rogosin Institute Scoring method for determining pancreas suitability for islet isolation

Also Published As

Publication number Publication date
EP1928249A4 (de) 2010-04-07
JP2009509507A (ja) 2009-03-12
US20070071732A1 (en) 2007-03-29
WO2007038029A3 (en) 2007-09-20
EP1928249B1 (de) 2012-02-29
PL1928249T3 (pl) 2012-11-30
CN101272690B (zh) 2012-08-29
NZ566621A (en) 2010-07-30
CA2622529A1 (en) 2007-04-05
HK1116995A1 (en) 2009-01-09
RU2417090C2 (ru) 2011-04-27
WO2007038029A2 (en) 2007-04-05
IL190028A0 (en) 2008-08-07
CN101272690A (zh) 2008-09-24
NO341154B1 (no) 2017-09-04
AU2006295114A1 (en) 2007-04-05
EP1928249A2 (de) 2008-06-11
CA2622529C (en) 2014-02-18
DK1928249T3 (da) 2012-06-18
RU2008114920A (ru) 2009-11-10
IL190028A (en) 2014-12-31
PT1928249E (pt) 2012-05-25
KR20080071122A (ko) 2008-08-01
JP4937265B2 (ja) 2012-05-23
ES2379008T3 (es) 2012-04-19
NO20081232L (no) 2008-04-23
AU2006295114B2 (en) 2010-01-28
US8518394B2 (en) 2013-08-27
KR101110386B1 (ko) 2012-03-08

Similar Documents

Publication Publication Date Title
ATE419629T1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
WO2006055689A3 (en) Protein scaffolds and uses thereof
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
DE602006005408D1 (de) API (Application Programming Interface) zum Erstellen von Anwendungen für P2P Nachrichtenaustausch
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
ATE315652T1 (de) Polypeptidzusammensetzungen von bacillus thuringiensis cryet70 die für diabrotica insekten toxisch sind, und methoden zur dessen verwendung
ATE299045T1 (de) Anorganische verbundmetalloxidkugeln mit grossen porenvolumen, ihre herstellung und ihre verwendungen bei adsorption und chromatographie
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
WO2007011857A3 (en) Low pungency, long day onion
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
ATE547004T1 (de) Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen
PL439807A1 (pl) Sposoby oczyszczania przeciwciał i ich kompozycje
ATE505549T1 (de) Männliche fertilitätvermittelnde nukleotidsequenzen und deren verwendung
DE50000767D1 (de) Mit nanopartikeln modifizierte bindemittel für überzugsmittel und deren verwendung
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
BR0309279A (pt) Macromoléculas em multicamadas e métodos para uso das mesmas
DE502007000372D1 (de) Schaumstoffsysteme, Kits und deren Verwendung
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
BR112018008113A2 (pt) veículo de cromatografia de afinidade e método para purificar a substância biológica
DK1226097T3 (da) Syntetisk silikatkugle-sammensætning og fremgangsmåde og anvendelse deraf
ATE274576T1 (de) 2,5-diketo-d-gluconsäure-reduktasen und deren anwendungen
WO2022026592A3 (en) Antibody molecules to coronavirus and uses thereof
EP1348767A3 (de) Polymer-chip und Verfahren zum Identifizieren eines ionischen Polymer